Do peptides help with longevity and healthy aging?
7 peptides are graded for longevity and healthy aging on this page. The strongest grade is human RCT evidence, for semaglutide and SS-31 (elamipretide). Each one is weighed against the standard of care below, and the evidence table gives the grade and a note for every peptide.
What is the standard of care for longevity and healthy aging?
Exercise, sleep, not smoking, blood pressure and lipid control, glycemic control, vaccination, and age appropriate cancer screening. No drug is approved to slow aging.
Any peptide below should be judged against this baseline, not against doing nothing. Talk to a licensed provider before replacing or adding to an established treatment.
Which peptides have been studied for longevity and healthy aging?
Ordered by strength of evidence for this use. Grades follow the methodology; each peptide page lists the individual studies.
| Peptide | Evidence for this use | Note |
|---|---|---|
| Semaglutide | Evidence: Human RCT evidence | 20% relative reduction in major adverse cardiovascular events in SELECT; no lifespan trial. [2] [3] |
| SS-31 (elamipretide) | Evidence: Human RCT evidence | Elamipretide trials in primary mitochondrial myopathy and Barth syndrome; mixed primary endpoints; FDA approved for Barth syndrome in 2025. [4] |
| NAD+ | Evidence: Human observational evidence | Not a peptide (a coenzyme). The record's human_rct grade is for muscle and metabolic endpoints of NAD+ precursors; there is no lifespan trial, and injectable NAD+ has no outcome trials. [11] |
| MOTS-c | Evidence: Animal-only evidence | Mitochondrial derived peptide that improved metabolic homeostasis in mice; the only human data are genetic association studies that do not raise the grade; FDA's drug center recommended against 503A listing and the advisory committee voted in favor (HHS policy, Appendix B); HHS's October 2026 draft policy, which is not an approval, covers conditional compounding of the single-ingredient product. [1] [13] |
| Humanin | Evidence: Animal-only evidence | Cytoprotective in animal models; no human trials. [5] |
| Epitalon | Evidence: Animal-only evidence | Telomere lengthening has been shown only in cultured human cells, and no human study has measured telomere length or life span after epitalon; two Russian human studies measured melatonin, with design and sample size not stated in their abstracts; the randomized trial often cited tested the pineal extract Epithalamin, not synthetic epitalon, so it does not raise the grade; FDA's drug center recommended against 503A listing and the advisory committee voted in favor (HHS policy, Appendix B); HHS's October 2026 draft policy, which is not an approval, covers conditional compounding of the single-ingredient product. [6] [7] [8] [9] [13] |
| FOXO4-DRI | Evidence: Animal-only evidence | Senolytic effects in aged mice; no human data. [10] |
Head-to-head comparisons
Cost and access
Price ranges, lawful channels, and insurance notes for peptides graded here. State rules are in the legal guides by state.
Frequently asked questions
Which peptide has the strongest evidence for longevity and healthy aging?
Semaglutide and SS-31 (elamipretide) have the strongest evidence among the peptides graded here, at human RCT evidence. Semaglutide: 20% relative reduction in major adverse cardiovascular events in SELECT; no lifespan trial. SS-31 (elamipretide): Elamipretide trials in primary mitochondrial myopathy and Barth syndrome; mixed primary endpoints; FDA approved for Barth syndrome in 2025. [2] [3] [4]
Is any peptide FDA approved for longevity and healthy aging?
Semaglutide and SS-31 (elamipretide) are FDA approved drugs, but an approval covers only the indications on that label, so check the label before assuming it applies to longevity and healthy aging. The other peptides graded here are not FDA approved. [2] [3] [4] [12]
Has any peptide been tested in a randomized trial for longevity and healthy aging?
Yes, for semaglutide and SS-31 (elamipretide). Check each note for the population and endpoints: a randomized trial in a related group or on a surrogate marker is weaker than one on the outcome you care about. [2] [3] [4]
From the blog
- Sermorelin vs HGH: mechanism, evidence, and legal status
Sermorelin signals the pituitary to release growth hormone; HGH (somatropin) is the hormone itself. Only somatropin is FDA approved today, and anti-aging use of either is off-label.
- Epitalon human studies: what the small cohorts actually measured
Most epitalon human data come from one group and used the pineal extract Epithalamin, not synthetic epitalon. What each study measured, the claimed benefits versus the evidence, and side effects.
Sources
- [1]The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance (Cell Metab 2015)PubMed 25738459, 2015
- [2]Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med 2023 (SELECT)PubMed 37952131, 2023
- [3]FDA prescribing information for Wegovy (semaglutide) injection, via DailyMedFDA, 2025
- [4]FDA prescribing information for Forzinity (elamipretide) injection, via DailyMedFDA, 2025
- [5]A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and AbetaPubMed 11371646, 2001
- [6]Epithalon peptide induces telomerase activity and telomere elongation in human somatic cellsPubMed 12937682, 2003
- [7]Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly peoplePubMed 17969590, 2007
- [8]AEDG peptide regulates human circadian rhythms genes expression during pineal gland accelerated agingPubMed 33280326, 2020
- [9]Peptides of pineal gland and thymus prolong human lifePubMed 14523363, 2003
- [10]Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and agingPubMed 28340339, 2017